Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Report

Market Insights

The Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market is estimated to grow from USD xx million in 2020 to USD xx million by 2026 at a healthy CAGR of 3.6% during the forecast period.

The increasing geriatric population, as well as lifestyle changes, leads to obesity, hypertension, hypertension, high blood pressure, and high level of cholesterol in the blood. Moreover, the growing prevalence of cardiovascular disease is likely to propel the growth of the percutaneous transluminal coronary angioplasty products market. In addition, the launch of advanced products and reclassification of some PTCA catheters from class III to class II devices by the FDA further augments the product demand.

COVID-19 Impact

The COVID-19 outbreak positively influenced the growth of the Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market. Rising cases of coronavirus across the globe put a heavy strain on the healthcare sector. Senior adults and people suffering from cardiovascular diseases were at higher risk of getting infected, which, in turn, boosted the demand for PTCA products.

What is percutaneous transluminal coronary angioplasty?

Percutaneous transluminal coronary angioplasty could be a minimally invasive procedure for opening blocked or narrowed coronary arteries caused by coronary arteries disease (CAD). Coronary heart diseases are primarily caused by smoking, resulting in an unhealthy lifestyle, high pressure level, diabetes, and a high level of cholesterol within the blood.

Key Players

Key players operating in the Percutaneous Transluminal Coronary Angioplasty (PTCA) products market are-

• Abbott Laboratories (US)
• Terumo (Japan)
• Boston Scientific (US)
• Intact Vascular (US)
• Asahi Intecc (Japan)
• Angioscore (US)
• Bard PV (US)
• Cook Medical (US)
• Cordis (US)
• Medtronic (US).

Segment Analysis

Product Trends

The product, the market has been bifurcated into PTCA balloon and PTCA guide. The infectious diseases segment accounted for a substantial market share in 2020. This is mainly attributed to rising cases of cardiovascular diseases across the globe. Also, the PTCA balloon is easy to use and safe. In addition, the cost associated with the PTCA balloon is relatively low, is likely to segment growth in the coming years.

Regional Analysis

The market in North America accounted for the largest share in 2020 and is projected to continue its dominance during the review period. This is mainly attributed to enhanced healthcare infrastructure coupled with several government initiatives. The growing incidences of cardiac disorders have further led to a surge in the demand for percutaneous transluminal coronary angioplasty products. A well-established healthcare system and high per capita healthcare expenditure are further augmenting up the growth of the Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market in the region.

To get the full scope of the report, Register Here

Target Audience

Here is the list of the group of customers that the market hopes to have the greatest opportunity to convert-

• Distributors
• Suppliers
• Manufacturers
• Logistics organizations
• Government bodies

Report Features

This report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

What deliverables will you get in this report?

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

Customization Options

Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to three players)
• SWOT analysis of key players (up to three players)

Competitive Benchmarking

Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.